AbbVie ( NYSE: ABBV )

AbbVie is a drug company with a strong exposure to immunology and oncology. The company’s top drug, Humira, represents close to half of the company’s current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women’s health. AbbVie ( NYSE: ABBV ) Quote.Price.last-update: 4:44 PM (Delayed 15-Minutes)

Get Real Time Here Open - Close - Vol / Avg. 517.000 / 6.227M Mkt Cap 350.543B Day Range - - - 52 Wk Range 163.810 - 218.660 Trade with Public Sell Compare Brokers Start Your Free 14-Day Benzinga Pro Trial

Immix Biopharma ( NASDAQ: IMMX )

Immix Biopharma Inc is a clinical-stage biopharmaceutical company developing Tissu

See Full Page